MedTrace Logo

Identifying Methylation Biomarkers for Monitoring Bladder Tumors

NCT00244205 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2005-11-15

No results posted yet for this study

Summary

To investigate the methylation status of 4-6 genes in Urine and matching bladder tissue biopsies, in order to find methylation markers for use in a noninvasive test in monitoring patients with bladder tumors.

Conditions

Interventions

PROCEDURE

Identifying genes methylated in urine

Sponsors & Collaborators

  • Copenhagen University Hospital at Herlev

    lead OTHER

Principal Investigators

  • Reza R Serizawa, MD · Copenhagen University Hospital at Herlev

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-11-30

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00244205 on ClinicalTrials.gov